Drug Discovery For Nervous System Disorders (R01 Clinical Trials Not Allowed)
Key Information
Due Date: January 7, 2025
Agency: U.S. Department of Health and Human Services (HHS)
Source: Federal
Funding Category:
Health & Human Services
Funding Amount: $581,371
Funding Type: Grant
Match Required: No
Contact Info:
OERWebmaster03@od.nih.gov
See Section VII. Agency Contacts within the full opportunity announcement for all other inquires.
Overview
The National Institute of Mental Health (NIMH) and the National Institute on Aging (NIA) sponsor the grant, aiming to initiate research into several areas. These include the identification, design, synthesis, and preclinical testing of potential therapeutic compounds. Additionally, the grant supports initial hit-to-lead chemistry to enhance the activity of compounds against the targeted disorder.
The grant also covers later-stage lead optimization to boost efficacy and improve drug metabolism and pharmacokinetics. The sponsors are particularly interested in projects that introduce innovative methods for identifying possible therapeutic agents.
Key Dates
Open Date: November 29, 2021
Application Due Date: January 7, 2025
Estimated Award Date: Not Specified
Additional Details
Eligible Activities
- Research and Development
Eligible Applicants
- State governments
- County governments
- City, village or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Private institutions of higher education
- Small businesses